4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-035515
Options or other derivatives
- Chief Executive Officer acquired 183,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kulkarni Samarth · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-20 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +105,000 | 105,000 | D |
| 2024-03-20 | Grant or award : show line 2 in the form Restricted Stock Units | +78,750 | 78,750 | D |
Loading xslF345X05/ownership.xml…